Advanced search: Search from
Select basic information for advanced search
| Free word |
|---|
Rchr
J-GLOBAL ID：201701017156732061
Update date: Apr. 13, 2025 TAKUYA YAMAMOTO
ヤマモト タクヤ | TAKUYA YAMAMOTO
National Institutes of Biomedical Innovation, Health and Nutrition
About National Institutes of Biomedical Innovation, Health and Nutrition
Job title： Director
Other affiliations (3)：
- Osaka University Graduate School of Medicine Guest Professor
- Osaka University Graduate School of Pharmaceutical Sciences
- 大阪国際がんセンター 次世代がん医療開発センター がん病態解析室 リサーチディレクター
Research theme for competitive and other funds (2)：
- 2024 - 2027 COVID-19 mRNAワクチン接種による記憶CD8 T細胞反応誘導メカニズムの解明とその応用
- 2022 - 2023 Establishment and applied research of novel infection model using innovative recombinant SARS-CoV-2 (P2 infection model, In vivo imaging, Mouse infection model)
- Shokichi Takahama, Ayaka Washizaki, Tomotaka Okamura, Shingo Kitamura, Takuto Nogimori, Yorifumi Satou, Yasuhiro Yasutomi, Tomokazu Yoshinaga, Takuya Yamamoto. The quality of SIV-specific fCD8 T cells limits SIV RNA production in Tfh cells during antiretroviral therapy. Journal of Virology. 2025
- Gaëlle Autaa, Laura Papagno, Takuto Nogimori, Andrea Boizard-Moracchini, Daniil Korenkov, Maeva Roy, Koichiro Suzuki, Yuji Masuta, Eoghann White, Sian Llewellyn-Lacey, et al. Ageing and inflammation limit the induction of SARS-CoV-2-specific CD8+ T cell responses in severe COVID-19. JCI insight. 2025
- Ayae Nishiyama, Takuto Nogimori, Yuji Masuta, Tomoka Matsuura, Tetsuo Kase, 近藤亨子, Satoko Ohfuji, Yu Nakagama, Natsuko Kaku, Sachie Nakagama, et al. Cross-Reactive Fc-Mediated Antibody Responses to Influenza HA Stem Region in Human Sera Following Seasonal Vaccination. Vaccines. 2025
- Atsushi Kawai, Taro Shimizu, Hiroki Tanaka, Shintaro Shichinohe, Jessica Anindita, Mika Hirose, Eigo Kawahara, Kota Senpuku, Makoto Shimooka, Le Thi Quynh Mai, et al. Low-inflammatory lipid nanoparticle-based mRNA vaccine elicits protective immunity against H5N1 high-pathogenicity avian influenza virus with reduced adverse reactions. Molecular therapy : the journal of the American Society of Gene Therapy. 2024
- Natsuko Kaku, Mayo Yasugi, Evariste Tshibangu-Kabamba, Yoshiyuki Wakabayashi, Yuko Uesaka, Yu Nakagama, Takuto Nogimori, Takuya Yamamoto, Placide Mbala-Kingebeni, Dieudonné Mumba Ngoyi, et al. Multiple-clone infections of Mpox: Insights from a single primary lesion. CMI Communications. 2024. 105042-105042
- 加来 奈津子, 城戸 康年, 中釜 悠, Tshibangu-Kabamba Evariste, 安木 真世, 山本 拓也, 野木森 拓人, Mbala-Kingebeni Placide, Mumba-Ngoyi Dieudonne, 安達 英輔. 天然痘ワクチン接種後免疫におけるエムポックス感染防御能把握のためのマイルストーン. グローバルヘルス合同大会プログラム・抄録集. 2023. 2023. 234-234
- 高濱正吉, 村上弘大, 秋田裕史, 秋田裕史, 長束佑太, 山本拓也. 膵臓がん患者におけるCD8+ T細胞応答増強のための免疫チェックポイント阻害剤治療介入の最適なタイミングの検討. 日本がん免疫学会総会プログラム・抄録集. 2023. 27th
- 高濱正吉, 野木森拓人, 西山紋恵, 鈴木孝一朗, 吉岡靖雄, 升田雄士, 山本拓也. Comprehensive analysis of CTL epitopes effective in suppressing COVID-19 severity using bioinformatics methods. 日本ウイルス学会学術集会プログラム・予稿集(Web). 2023. 70th
- The role of Follicular helper CD4 T cells in HIV/SIV infection
The Japanese Society for Virology 2012
- 2023/04 - 現在 National Institutes of Biomedical Innovation, Health and Nutrition Center for Intractable Diseases and ImmunoGenomics Director
- 2021/08 - 現在 Osaka University Graduate School of Medicine
- 2021/05 - 現在 大阪国際がんセンター 次世代がん医療開発センター がん病態解析室 リサーチディレクター
- 2019 - 現在 国立感染症研究所 治療薬・ワクチン開発研究センター 客員研究員
- 2019 - 現在 Kumamoto University
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.
Return to Previous Page
